Search Saint Luke's

We are honored you have chosen Saint Luke’s for your health care needs. Please review the following information to help prepare for your hospital stay.

Julie Quirin, FACHE, retiring after nearly 30 years of service with Saint Luke’s.

Jani Johnson retiring after 40 years of service with Saint Luke’s

Coronary Artery Disease
A randomized controlled study of the Prevail Drug-Coated Balloon in subjects with in-stent restenosis and a single arm prospectively enrolled study of the Prevail Drug-Coated Balloon for de novo lesions in small vessel disease (Prevail Global)

Cardiometabolic

A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death in Participants with Increased Risk of Developing Heart Failure

The accredited Preventive Cardiology Fellowship at Saint Luke's Hospital of Kansas City focuses on the medical therapy of atherosclerosis and coronary artery disease.

Mitral Valve

Percutaneous or surgical Repair In Mitral prolapse And Regurgitation for ≥ 65 Year-olds

While it’s common to associate heart health with cardiologists, primary care providers play an important role in heart health by being your first line of defense and determining your risk for heart disease.

Saint Luke’s Health System, Inc. (“Saint Luke’s”, “we”, “us” or “our”) respects your privacy and is committed to protecting it through our compliance with this policy.

Heart Failure 
A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II -III Heart Failure Patients (PROACTIVE- HF-2 Trial)